Skip to main navigation Skip to search Skip to main content

KIT FOR EVALUATING THROMBOMODULIN MRNA IN MATERNAL BLOOD FOR THE EARLY PREDICTION OF PRE-ECLAMPSIA

Research output: Innovation ProductsInvention patent

Abstract

Disclosed are: nucleic acid molecules of the type messenger RNA (mRNA); kits for detecting thrombomodulin mRNA in maternal blood by means of real-time PCR, which comprise the molecules; and a method for the early screening of pre-eclampsia by detecting thrombomodulin mRNA levels in plasma by means of real-time PCR using the kits.

Original languageEnglish
Publication/registration numberWO2023073650
International ClassificationC12Q 1/ 6809 A I
Grant date 28/10/21
Filing date28/11/22
StateIn preparation - 04 May 2023

Fingerprint

Dive into the research topics of 'KIT FOR EVALUATING THROMBOMODULIN MRNA IN MATERNAL BLOOD FOR THE EARLY PREDICTION OF PRE-ECLAMPSIA'. Together they form a unique fingerprint.

Cite this